Literature DB >> 27087491

Lipid Nanoparticles and their Application in Nanomedicine.

Mehdi Rajabi, Shaker A Mousa1.   

Abstract

In recent years many different nanotechnology platforms have been developed for both diagnostics and cancer therapy. Researchers have been attracted to use lipid-based nanoparticles with particle size approximately 100 nm as a new pharmaceutical delivery system or pharmaceutical formulation that can be assembled from different types of lipid or other chemical components in order to overcome biological barriers. This mini-review highlights the recently published studies in the development of lipid-based nanoparticles as appropriate vehicles in cancer diagnosis and therapy with focus on their chemical structure, formulation recipes, stability, drug encapsulation, and other factors related to their formulation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27087491     DOI: 10.2174/1389201017666160415155457

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  8 in total

Review 1.  Nanoparticles in the diagnosis and treatment of vascular aging and related diseases.

Authors:  Hui Xu; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

Review 2.  Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer.

Authors:  Aleksandra Benko; David Medina-Cruz; Ada Vernet-Crua; Catherine P O'Connell; Małgorzata Świętek; Hamed Barabadi; Muthupandian Saravanan; Thomas J Webster
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 3.  Nanovehicles in the improved treatment of infections due to brain-eating amoebae.

Authors:  Mohammad Ridwane Mungroo; Naveed Ahmed Khan; Ayaz Anwar; Ruqaiyyah Siddiqui
Journal:  Int Microbiol       Date:  2021-08-09       Impact factor: 2.479

4.  Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation.

Authors:  Federica De Gaetano; Maria Chiara Cristiano; Valentina Venuti; Vincenza Crupi; Domenico Majolino; Giuseppe Paladini; Giuseppe Acri; Barbara Testagrossa; Alessia Irrera; Donatella Paolino; Silvana Tommasini; Cinzia Anna Ventura; Rosanna Stancanelli
Journal:  Molecules       Date:  2021-02-16       Impact factor: 4.411

Review 5.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

6.  Nano-colloidal carrier via polymeric coating for oral delivery of isradipine.

Authors:  Vikash Kumar; Hema Chaudhary; Anjoo Kamboj
Journal:  Interv Med Appl Sci       Date:  2017-12

7.  Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.

Authors:  Maryam Ebrahimi Nik; Bizhan Malaekeh-Nikouei; Mohamadreza Amin; Mahdi Hatamipour; Manouchehr Teymouri; Hamid Reza Sadeghnia; Mehrdad Iranshahi; Mahmoud Reza Jaafari
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

Review 8.  Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review.

Authors:  Yosif Almoshari
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.